NCT01896700View on ClinicalTrials.gov

Methylphenidate to Improve Balance and Walking in MS

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Multiple Sclerosis
Interventions
DRUG

Methylphenidate

Escalating dose of methylphenidate, 20mg, 40mg, 60mg/day, for 2 weeks each

DRUG

Placebo

Escalating matched dose of placebo

Trial Locations (1)

97239

Portland VA Medical Center, Portland

All Listed Sponsors
collaborator

Portland VA Medical Center

FED

lead

Oregon Health and Science University

OTHER

NCT01896700 - Methylphenidate to Improve Balance and Walking in MS | Biotech Hunter | Biotech Hunter